Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
Completed
Conditions studied: Lung Cancer
In brief
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Key facts
- Study ID
- NCT00185913
- Run by
- Stanford University
- People needed
- 50
- Starts
- 2000-09-01
- Expected to finish
- 2008-05-01
- Last updated by the study team
- 2010-04-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.